Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Pacira BioSciences Inc (NASDAQ: PCRX) was $26.14 for the day, down -2.28% from the previous closing price of $26.75. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
Our analysis of PCRX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.59. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 2.41. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on January 30, 2025, Upgraded its rating to Hold and sets its target price to $25 from $8 previously.
On August 13, 2024, Truist Downgraded its rating to Sell which previously was Buy and also lowered its target price recommendation from $30 to $8.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on August 12, 2024, whereas the target price for the stock was revised from $37 to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’25 when GAUGLER DARYL bought 500 shares for $23.25 per share.
SLONIN JONATHAN sold 879 shares of PCRX for $16,174 on Jan 06 ’25. The Chief Medical Officer now owns 93,444 shares after completing the transaction at $18.40 per share. On Jan 06 ’25, another insider, SLONIN JONATHAN, who serves as the Officer of the company, bought 879 shares for $18.40 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 1.52.
Stock Price History:
Over the past 52 weeks, PCRX has reached a high of $31.64, while it has fallen to a 52-week low of $11.16. The 50-Day Moving Average of the stock is 4.86%, while the 200-Day Moving Average is calculated to be 28.79%.
Shares Statistics:
A total of 46.28M shares are outstanding, with a floating share count of 44.27M. Insiders hold about 4.39% of the company’s shares, while institutions hold 111.27% stake in the company.
